Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Macrolide; peptidyl transferase inhibitor, prot...
Intermediate in the synthesis of purine analogs...
Endogenous neuropeptide hormone, lowers extrace...
Potential anxiolytic.
mGluR5 positive modulator.
Hexokinase inhibitor, aerobic glycolysis inhibi...
ATP-sensitive K+ channel blocker, potential RyR...
Heterocyclic light-emitting compound, natural l...
Mycotoxin contaminant found in cereal grains.
Mixture of alkylphenols found in Ginkgo; HIV pr...
NS3/4A serine protease inhibitor.
Salicylic acid derivative; PPARγ agonist, pote...
Steroid; glucocorticoid agonist.
M4 mAChR agonist, 5-HT1A partial agonist, M1/2/...
ERK2 inhibitor, potential AurKA, GSK3, CDK2, FL...
Peptide, neurotensin analog.
Nucleoside (guanosine) analog; RT, guanylyl cyc...
GABA analog; GABA potentiator, adenosine A1 ago...
Mcl-1 inhibitor